• Osteoporosis is a risk factor for people with RA and JIA

    RA news | 30 Oct 2018

    See the following press release about an important new report on the state of play of osteoporosis in the UK.

  • Millions of Pounds to be saved in NHS with introduction of Adalimumab biosimilars

    RA news | 15 Oct 2018

    The first biosimilars to be introduced in rheumatology came to the UK market in early 2015, however, their use in rheumatoid arthritis is set to soar with the introduction of 4 biosimilars when Adalimumab comes off patent on 16th October, 2018.

  • Latest news on Best Value Biologics: Biosimilars

    RA news | 24 Sep 2018

    Biosimilar medicines represent very good value for the NHS since they are often much less costly than the originator medicine. Therefore the NHS is asking clinical teams, in discussion with individual patients, to ensure they are using the best value biological medicines – whether that is the originator biological medicine or a new biosimilar medicine – so that the money saved can be reinvested in new medicines and treatments for patients.

View news archive